Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.790
-0.010 (-0.56%)
Aug 18, 2026, 10:50 AM EDT - Market open
Cardiol Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Cardiol Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $7.89. The average 1-year stock price forecast is 340.78% higher than the current stock price, while the lowest is $4.95 (+176.54%) and the highest is $10 (+458.66%).
Price Target: $7.89 (+340.78%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cardiol Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $8 → $10 | Buy | Reiterates | $8 → $10 | +458.66% | Aug 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $9 | Buy | Reiterates | $9 | +402.79% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
1.18M
EPS This Year
-0.33
from -0.39
EPS Next Year
-0.30
from -0.33
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.